Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
A tale of two lung cancer immunotherapies: Merck's Keytruda takes the reins
Medical Marketing and Media
Wed, 05/2/18 - 12:01 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
CP Wire
Wed, 04/25/18 - 09:55 am
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Tue, 04/24/18 - 11:17 pm
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer
Fierce Pharma
Mon, 04/16/18 - 11:36 pm
Bristol-Myers Squibb
Opdivo
Yervoy
kidney cancer
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Sat, 04/14/18 - 01:18 pm
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
With big Keytruda and Opdivo data coming at AACR, analyst hands Merck the early edge
Fierce Pharma
Fri, 04/13/18 - 12:55 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
AACR
PDUFA test
Tue, 04/10/18 - 12:16 am
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
Fri, 04/6/18 - 12:00 am
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Thu, 04/5/18 - 11:40 pm
Opdivo
ALT-803
Bristol-Myers Squibb
Altor Bioscience
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Fierce Pharma
Tue, 03/27/18 - 09:56 pm
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
colorectal cancer
[video]How Convenience Can Give Drugmakers a Competitive Edge
Motley Fool
Tue, 03/13/18 - 10:08 am
convenience
Merck
Bristol-Myers Squibb
dosing
Opdivo
Keytruda
FDA approves new dosing for Bristol-Myers Squibb's Opdivo
Yahoo/Reuters
Tue, 03/6/18 - 09:46 am
FDA
Bristol-Myers Squibb
Opdivo
dosing
cancer
melanoma
More Questions Than Answers For Bristol-Myers
Forbes
Tue, 02/6/18 - 09:18 am
Bristol-Myers Squibb
Opdivo
Yervoy
Bristol claims victory in crucial immunotherapy trial, but results raise some questions
Stat
Mon, 02/5/18 - 11:52 am
Bristol-Myers Squibb
Opdivo
Yervoy
advanced lung cancer
Bristol-Myers surges 5.6% on advanced lung cancer trial results, Q4 earnings
Marketwatch
Mon, 02/5/18 - 08:33 am
Bristol-Myers Squibb
earnings
Opdivo
Yervoy
advanced lung cancer
Opdivo-Yervoy combo 'encouraging' in colorectal cancer
Biopharma Dive
Mon, 01/22/18 - 10:54 am
Opdivo
Yervoy
Bristol-Myers Squibb
colorectal cancer
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Wed, 01/17/18 - 10:05 am
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Merck's Keytruda nabs new data to rival Bristol-Myers' Opdivo at fending off melanoma's return
Fierce Pharma
Mon, 01/15/18 - 10:37 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
melanoma
Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
Fierce Pharma
Fri, 01/5/18 - 10:28 am
China
Opdivo
Repatha
Lynparza
drug approvals
Bristol-Myers Squibb
Amgen
AstraZeneca
Eli Lilly
Gilead Sciences
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »